Gary Titus
2017
In 2017, Gary Titus earned a total compensation of $1.1M as Former Chief Financial Officer at UroGen Pharma Ltd., a 168% increase compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $125,125 |
| Option Awards | $622,224 |
| Salary | $304,167 |
| Other | $1,161 |
| Total | $1,077,677 |
Titus received $622.2K in option awards, accounting for 58% of the total pay in 2017.
Titus also received $25K in bonus, $125.1K in non-equity incentive plan, $304.2K in salary and $1.2K in other compensation.
Rankings
In 2017, Gary Titus' compensation ranked 8,629th out of 14,666 executives tracked by ExecPay. In other words, Titus earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,629 out of 14,666 | 41st |
Division Manufacturing | 3,276 out of 5,768 | 43rd |
Major group Chemicals And Allied Products | 1,099 out of 2,074 | 47th |
Industry group Drugs | 871 out of 1,730 | 50th |
Industry Pharmaceutical Preparations | 682 out of 1,329 | 49th |
Source: SEC filing on April 26, 2019.
Titus' colleagues
We found three more compensation records of executives who worked with Gary Titus at UroGen Pharma Ltd. in 2017.